167 related articles for article (PubMed ID: 7927816)
1. Foscarnet and ganciclovir combination therapy for CMV disease in HIV-infected patients.
Salzberger B; Stoehr A; Heise W; Fätkenheuer G; Schwenk A; Franzen C; Cornely O; Schrappe M
Infection; 1994; 22(3):197-200. PubMed ID: 7927816
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
Parente F; Bianchi Porro G
Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome.
Wilcox CM; Straub RF; Schwartz DA
Am J Med; 1995 Feb; 98(2):169-76. PubMed ID: 7847433
[TBL] [Abstract][Full Text] [Related]
4. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
5. Current management of cytomegalovirus disease in patients with AIDS.
Jacobson MA
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
[TBL] [Abstract][Full Text] [Related]
6. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease.
Balfour HH
Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708
[TBL] [Abstract][Full Text] [Related]
9. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Jacobson MA; Wulfsohn M; Feinberg JE; Davis R; Power M; Owens S; Causey D; Heath-Chiozzi ME; Murphy RL; Cheung TW
AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
[TBL] [Abstract][Full Text] [Related]
10. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
[TBL] [Abstract][Full Text] [Related]
11. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151.
Jacobson MA; Kramer F; Bassiakos Y; Hooton T; Polsky B; Geheb H; O'Donnell JJ; Walker JD; Korvick JA; van der Horst C
J Infect Dis; 1994 Jul; 170(1):189-93. PubMed ID: 8014496
[TBL] [Abstract][Full Text] [Related]
13. Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot study.
Peters M; Schürmann D; Bergmann F; Grünewald T; Timm H; Pohle HD; Ruf B
Scand J Infect Dis; 1994; 26(1):49-54. PubMed ID: 8191240
[TBL] [Abstract][Full Text] [Related]
14. Identification and treatment of cytomegalovirus retinitis in patients with AIDS.
Speyrer MP
J Am Acad Nurse Pract; 1997 Jul; 9(7):329-31. PubMed ID: 9274255
[No Abstract] [Full Text] [Related]
15. Foscarnet or ganciclovir for treatment of AIDS and CMV retinitis.
Moyle G; Gazzard BG
Am J Med; 1995 Mar; 98(3):319-20. PubMed ID: 7872356
[No Abstract] [Full Text] [Related]
16. Cytomegalovirus infection in patients with HIV infection.
Cheung TW; Teich SA
Mt Sinai J Med; 1999 Mar; 66(2):113-24. PubMed ID: 10100416
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.
Patel SS; Rutzen AR; Marx JL; Thach AB; Chong LP; Rao NA
Ophthalmology; 1996 Sep; 103(9):1476-82. PubMed ID: 8841309
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
Tural C; Romeu J; Sirera G; Andreu D; Conejero M; Ruiz S; Jou A; Bonjoch A; Ruiz L; Arnó A; Clotet B
J Infect Dis; 1998 Apr; 177(4):1080-3. PubMed ID: 9534987
[TBL] [Abstract][Full Text] [Related]
19. New treatment options for CMV retinitis in AIDS.
Lalezari JP
Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
[No Abstract] [Full Text] [Related]
20. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction.
Dieterich DT; Poles MA; Dicker M; Tepper R; Lew E
Am J Gastroenterol; 1993 Apr; 88(4):542-8. PubMed ID: 8385880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
